I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients

I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Enrolling By Invitation
18 years - 99 years
All
Phase N/A
100 participants needed

Brief description of study

A trial to compare different investigational agents for their ability to improve clinical outcomes n severely ill patients with COVID-19 pneumonia.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: COVID-19 pneumonia,Covid-19 Pnemonia
  • Age: 18 years - 99 years
  • Gender: All

Male and Female Age 18 and over Covid-19 Pneumonia

Updated on 02 Jul 2025. Study ID: 843758
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research